Trial intelligence / Profile preview

Evaluation of antibiotic therapy combined with corticosteroids in severe alcoholic hepatitis

2014-002536-13Phase 3Completed

Sponsor
CHU de Lille
Start
Jun 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in alcoholic hepatitis (AH) comparing Corticosteroids alone with Corticosteroids + Augmentin (2 arms). Primary endpoint: 2-month survival rate. Started Jun 2016; status: completed.

02

Drugs

amoxicillin + clavulanateprednisolone
03

Conditions

alcoholic hepatitis (AH)

Beyond the preview

Go deeper on 2014-002536-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002536-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call